Trident Texofab Limited has submitted to exchange Newspaper Advertisement for Publication of Unaudited Financial Result for the Quarter and Nine Months ended on 31.12.2024
Trident Texofab Ltd. Press Release Feb 05 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Trident Texofab
- Announcement under Regulation 30 (LODR)-Investor Presentation
- Trident Texofab Ltd. Press Release Feb 03 2025
- Integrated Filing (Financial)
- Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 31.12.2024
- Result-Financial Result For The Quarter And Nine Months Ended On 31.12.2024
Later from Trident Texofab
- Board Meeting Outcome for Meeting Of The Company Held On Monday, March 17, 2025
- Outcome Of Board Meeting Held On Monday, March 17, 2025
- Announcement under Regulation 30 (LODR)-Conversion of Securities
- Trident Texofab Ltd. Press Release Mar 17 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, March 20, 2025
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab